Air

Air Emissions
GlaxoSmithKline operations can emit a range of air pollutants including:

• Carbon dioxide (CO2) from the energy that we use to power our processes and to heat, cool and light our facilities, CO2 generated from some manufacturing operations and CO2 generated by the fuels that power the vehicles and aircraft we use to transport our products and people

• Sulphur dioxide (SO2 ) and nitrogen oxides (NOx) from the energy that we use to power our processes and to heat, cool and light our facilities

• Ozone Depleting Substances (ODSs) (e.g. chlorofluorocarbons, hydrochlorofluorocarbons and hydrofluorocarbons) released in the course of manufacturing our metered dose inhalers, used in refrigeration equipment in some of our manufacturing facilities and released when patients use our metered dose inhalers

• Volatile organic compounds (VOCs) from our manufacturing operations

These releases have the potential to affect climate (global warming), deplete the ozone layer, generate smog and create acid rain. Additionally, some of these substances when released into the air can cause a variety of health impacts because of the way they react with other substances in the air.

EHS Home | Download this Report | GSK.com

Updated June 20, 2004 © 2001-2005 GlaxoSmithKline - All Rights Reserved
Legal Notices - Privacy Statement - Accessibility